Pfizer (PFE) takes up an option acquire privately held NextWave Pharmaceuticals, which develops...

|About: Pfizer Inc. (PFE)|By:, SA News Editor

Pfizer (PFE) takes up an option acquire privately held NextWave Pharmaceuticals, which develops Quillivant XR, a treatment for attention deficit/hyperactivity disorder (ADHD). Pfizer will pay $255M upfront and milestone amounts of up to $425M. The FDA approved Quillivant in September and the drug is expected to go on sale in January. (PR)